The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Tissue Inhibitor of Metalloproteinases–1 Promotes Liver Fibrosis Development in A Transgenic Mouse Model
Open accessAbstract
Tissue inhibitor of metalloproteinases–1 (TIMP–1) has been shown to be increased in liver fibrosis development both in murine experimental models and human samples. However, the direct role of TIMP–1 during liver fibrosis development has not been defined. To address this issue, we developed transgenic mice overexpressing human TIMP–1 (hTIMP–1) in the liver under control of the albumin promoter/enhancer. A model of CCl 4–induced hepatic fibrosis was used to assess the extent of fibrosis development in TIMP–1 transgenic (TIMP–Tg) mice and control hybrid (Cont) mice. Without any treatment, overexpression of TIMP–1 itself did not induce liver fibrosis. There were no significant differences of pro–(α1)–collagen–I, (α2)–collagen–IV, and α–smooth muscle actin (α–SMA) mRNA expression in the liver between TIMP–Tg and Cont–mice, suggesting that overexpression of TIMP–1 itself did not cause hepatic stellate cell (HSC) activation. After 4–week treatment with CCl 4, however, densitometric analysis revealed that TIMP–Tg–mice had a seven–fold increase in liver fibrosis compared with the Cont–mice. The hepatic hydroxyproline content and serum hyaluronic acid were also significantly increased in TIMP–Tg–mice, whereas CCl 4–induced liver dysfunction was not altered. An active form of matrix metalloproteinases–2 (MMP–2) level in the liver of TIMP–Tg–mice was decreased relative to that in Cont–mice because of the transgenic TIMP–1. Immunohistochemical analysis revealed that collagen–I and collagen–IV accumulation was markedly increased in the liver of CCl 4–treated TIMP–Tg–mice with a pattern similar to that of α–SMA positive cells. These results suggest that TIMP–1 does not by itself result in liver fibrosis, but strongly promotes liver fibrosis development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
Metalloproteinases and their inhibitors in matrix remodeling
Matrisian, L. M. (1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90126-q · Cited by 1,605
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez, D. E., Alonso, D. F., Yoshiji, H., & Thorgeirsson, U. P. (1997) · PubMed · Cited by 1,508
Self-citationIredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Sanderson, N., Factor, V, Nagy, P., Kopp, J., Kondaiah, P., Wakefield, L., Roberts, A. B., Sporn, M. B., & Thorgeirsson, S. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2572 · Cited by 671
Self-citationWill, H., Atkinson, S. J., Butler, G. S., Smith, B., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17119 · Cited by 569
Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4
Greene, J., Wang, M., Liu, Y. E., Raymond, L. A., Rosen, C., & Shi, Y. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30375 · Cited by 555
Guedez, L., Stetler-Stevenson, W. G., Wolff, L., Wang, J., Fukushima, P., Mansoor, A., & Stetler-Stevenson, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2881 · Cited by 397
Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver
Benyon, R., Iredale, J., Goddard, S., Winwood, P., & Arthur, M. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608892 · Cited by 353
Iredale, J. P., Benyon, R. C., Arthur, M. J., Ferris, W. F., Alcolado, R., Winwood, P. J., Clark, N., & Murphy, G. (1996) · Hepatology · doi:10.1002/hep.510240129 · Cited by 324
Pinkert, C. A., Ornitz, D. M., Brinster, R. L., & Palmiter, R. D. (1987) · Genes & Development · doi:10.1101/gad.1.3.268 · Cited by 315
Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells.
Li, G., Fridman, R., & Kim, H.-R. C. (1999) · PubMed · Cited by 256
Molecular regulation of hepatic fibrogenesis
Olaso, E., & Friedman, S. L. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80269-9 · Cited by 244
Milani, S., Herbst, H., Schuppan, D., Grappone, C., Pellegrini, G., Pinzani, M., Casini, A., Calabró, A., Ciancio, G., & Stefanini, F. (1994) · PubMed Central · Cited by 244
Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis.
Herbst, H., Wege, T., Milani, S., Pellegrini, G., Orzechowski, H., Bechstein, W. O., Neuhaus, P., Gressner, A. M., & Schuppan, D. (1997) · Europe PMC (PubMed Central) · Cited by 210
Iredale, J. P., Murphy, G., Hembry, R. M., Friedman, S. L., & Arthur, M. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115850 · Cited by 202
Kossakowska, A. E., Edwards, D. R., Lee, S. S., Urbanski, L. S., Stabbler, A. L., Zhang, C.-L., Phillips, B. W., Zhang, Y., & Urbanski, S. J. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65703-3 · Cited by 184
Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats
Takahara, T., Furui, K., Funaki, J., Nakayama, Y., Itoh, H., Miyabayashi, C., Sato, H., Seiki, M., Ooshima, A., & Watanabe, A. (1995) · Hepatology · doi:10.1002/hep.1840210328 · Cited by 168
Tissue inhibitors of metalloproteinases in liver fibrosis
Iredale, J. P. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00118-5 · Cited by 165
Oliver, G. W., Leferson, J. D., Stetler-Stevenson, W. G., & Kleiner, D. E. (1997) · Analytical Biochemistry · doi:10.1006/abio.1996.9895 · Cited by 164
Guédez, L., Courtemanch, L., & Stetler‐Stevenson, M. (1998) · Blood · doi:10.1182/blood.v92.4.1342 · Cited by 154
Identification of a Stimulator of Steroid Hormone Synthesis Isolated from Testis
Boujrad, N., Ogwuegbu, S. O., Garnier, M. J., Lee, C., Martin, B. M., & Papadopoulos, V. (1995) · Science · doi:10.1126/science.7777858 · Cited by 149
Benyon, C. R., Hovell, C. J., Gaça, M., Jones, E. H., Iredale, J. P., & Arthur, M. J. P. (1999) · Hepatology · doi:10.1002/hep.510300431 · Cited by 140
Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis
Arthur, M. J. P., Mann, D. A., & Iredale, J. P. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.1998.13.s1.33 · Cited by 138
Iredale, J. P., Goddard, S., Murphy, G., Benyon, R. C., & Arthur, M. J. P. (1995) · Clinical Science · doi:10.1042/cs0890075 · Cited by 110
Kasahara, A., Hayashi, N., Mochizuki, K., Oshita, M., Katayama, K., Kato, M., Masuzawa, M., Yoshihara, H., Naito, M., Miyamoto, T., et al. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80423-0 · Cited by 105
Factor, V. M., Kao, C. Y., Santoni‐Rugiu, E., Woitach, J. T., Jensen, M. R., & Thorgeirsson, S. S. (1997) · PubMed · Cited by 103
Self-citationZhao, W., Li, H., Yamashita, K., Guo, X., Hoshino, T., Yoshida, S., Shinya, T., & Hayakawa, T. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.9.1147 · Cited by 97
Ritter, L. M., Garfield, S. H., & Thorgeirsson, U. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0408 · Cited by 95
Self-citationTissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease
Murawaki, Y., Ikuta, Y., Idobe, Y., Kitamura, Y., & Kawasaki, H. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80454-0 · Cited by 85
Degradation of Matrix Proteins in Liver Fibrosis
Arthur, M. J. P. (1994) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80985-4 · Cited by 76
Murawaki, Y., Yamamoto, H., Kawasaki, H., & Shima, H. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90221-o · Cited by 55
Fibrosis Accelerates the Development of Enzyme–Altered Lesions in the Rat Liver
Sakaida, I., Hironaka, K., Uchida, K., Suzuki, C., Kayano, K., & Okita, K. (1998) · Hepatology · doi:10.1002/hep.510280512 · Cited by 55
Factor, V. M., Jensen, M. R., & Thorgeirsson, S. S. (1997) · Hepatology · doi:10.1002/hep.510260610 · Cited by 37
Self-citationYamamoto, T., Terada, N., Seiyama, A., Nishizawa, Y., Akedo, H., & Kosaka, H. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980105)75:1<81::aid-ijc13>3.0.co;2-g · Cited by 21
Extracellular-matrix gene expression during mouse submandibular gland development
Macauley, S. P., Tarnuzzer, R. W., Schultz, G. S., et al. (1997) · Archives of Oral Biology · doi:10.1016/s0003-9969(97)00027-7 · Cited by 18
Cited by
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866
Roles of TGF-beta in hepatic fibrosis
Gressner, A. M. (2002) · Frontiers in Bioscience · doi:10.2741/a812 · Cited by 783
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741
Diverse functions of matrix metalloproteinases during fibrosis
Giannandrea, M., & Parks, W. C. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.012062 · Cited by 541
Apoptosis: The nexus of liver injury and fibrosis
Canbay, A., Friedman, S., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20051 · Cited by 527
Metadata
- Authors
- Yoshiji, H., Kuriyama, S., Miyamoto, Y., Thorgeirsson, U. P., Gomez, D. E., Kawata, M., Yoshii, J., Ikenaka, Y., Noguchi, R., Tsujinoue, H., Nakatani, T., Thorgeirsson, S. S., & Fukui, H.
- Venue
- Hepatology
- Published
- 2000-12
- Volume
- 32
- Issue
- 6
- Pages
- 1248-1254
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2077455531
- Cited by
- 252
- References
- 36
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.